← Back to front page
Asia · General news · The Korea Herald

Samsung Bioepis secures 10-year biosimilar supply deal in Brazil

Published by The Korea Herald · South Korea 13 h ago

Samsung Bioepis said Tuesday it has secured a 10-year deal to exclusively supply its rare disease biosimilar SB12 to Brazil's public health system, strengthenin ...

Read the full article on The Korea Herald Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.koreaherald.com)

Also worth reading

Philippine Daily Inquirer

Magnitude 6.3 earthquake strikes off Vanuatu

 Yonhap

Today in Korean history

 Asia Times

Ghosts of ’97 haunt Prabowo as MSCI eyes Indonesia’s exit

 The Mainichi

Rare photos of Myanmar's Suu Kyi getting letters from British king released

 Hindustan Times

The science and politics behind the panic over ultraprocessed foods

 CNA

Singapore tech giant Sea plans IPO for financial services arm Monee, memo says